Neogen Corporation Restructuring Charges
Neogen Corporation (NEOG) reported Restructuring Charges of $7.00 million for the 12-month period ending 2026-05-31, per its 10-K filed 2026-07-30.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:RestructuringCharges · last filed 2026-07-30
- Neogen Corporation restructuring charges for the quarter ending 2026-05-31 was $100.00K, a 90.00% decline year-over-year.
- Neogen Corporation restructuring charges for the quarter ending 2026-02-28 was $400.00K, a 100.00% increase year-over-year.
- Neogen Corporation restructuring charges for the quarter ending 2025-11-30 was $6.13M, a 35.98% decline year-over-year.
- Neogen Corporation restructuring charges for the quarter ending 2025-08-31 was $332.00K, a 10.27% decline year-over-year.
- Neogen Corporation restructuring charges for fiscal 2026 was $7.00M, a 36.94% decline from fiscal 2025.
- Neogen Corporation restructuring charges for fiscal 2025 was $11.10M, a 215.97% increase from fiscal 2024.
- Neogen Corporation restructuring charges for fiscal 2024 was $3.51M.
| Period end | Restructuring Charges 3 month | Restructuring Charges 3 month as first filed | Restructuring Charges 6 month | Restructuring Charges 9 month | Restructuring Charges 9 month as first filed | Restructuring Charges 12 month | Restructuring Charges 12 month as first filed |
|---|---|---|---|---|---|---|---|
| 2026-05-31 | $100.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-07-30 | $500.00K derived: sum of 2 quarters · filed 2026-07-30 | $6.63M derived: sum of 3 quarters · filed 2026-07-30 | $7.00M 10-K · filed 2026-07-30 | |||
| 2026-02-28 | $400.00K 10-Q · filed 2026-04-09 | $6.53M derived: sum of 2 quarters · filed 2026-04-09 | $6.90M 10-Q · filed 2026-04-09 | $7.86M derived: sum of 4 quarters · filed 2026-07-30 | |||
| 2025-11-30 | $6.13M 10-Q · filed 2026-01-08 | $6.46M 10-Q · filed 2026-01-08 | $7.46M derived: sum of 3 quarters · filed 2026-07-30 | $7.66M derived: sum of 4 quarters · filed 2026-07-30 | |||
| 2025-08-31 | $332.00K 10-Q · filed 2025-10-09 | $1.33M derived: sum of 2 quarters · filed 2026-07-30 | $1.53M derived: sum of 3 quarters · filed 2026-07-30 | $11.10M derived: sum of 4 quarters · filed 2026-07-30 | |||
| 2025-05-31 | $1.00M derived: 10-K 12 month − 10-Q 9 month · filed 2026-07-30 | $1.20M derived: sum of 2 quarters · filed 2026-07-30 | $10.77M derived: sum of 3 quarters · filed 2026-07-30 | $11.10M 10-K · filed 2026-07-30 | $11.10M 10-K · filed 2025-07-30 | ||
| 2025-02-28 | $200.00K 10-Q · filed 2026-04-09 | $168.00K 10-Q · filed 2025-04-09 | $9.77M derived: sum of 2 quarters · filed 2026-04-09 | $10.10M 10-Q · filed 2026-04-09 | $10.11M 10-Q · filed 2025-04-09 | $10.30M derived: sum of 4 quarters · filed 2026-04-09 | |
| 2024-11-30 | $9.57M 10-Q · filed 2026-01-08 | $9.94M 10-Q · filed 2026-01-08 | $10.10M derived: sum of 3 quarters · filed 2026-01-08 | $11.04M derived: sum of 4 quarters · filed 2026-01-08 | |||
| 2024-08-31 | $370.00K 10-Q · filed 2025-10-09 | $530.00K derived: sum of 2 quarters · filed 2025-10-09 | $1.47M derived: sum of 3 quarters · filed 2025-10-09 | $3.32M derived: sum of 4 quarters · filed 2025-10-09 | |||
| 2024-05-31 | $160.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-07-30 | $1.10M derived: sum of 2 quarters · filed 2025-07-30 | $2.95M derived: sum of 3 quarters · filed 2025-07-30 | $3.51M 10-K · filed 2025-07-30 | |||
| 2024-02-29 | $938.00K 10-Q · filed 2025-04-09 | $2.79M derived: sum of 2 quarters · filed 2025-04-09 | $3.35M 10-Q · filed 2025-04-09 | ||||
| 2023-11-30 | $1.86M 10-Q · filed 2025-01-15 | $2.42M 10-Q · filed 2025-01-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Celldex Therapeutics, Inc. (CLDX) | United States | $2.471B | -9.72 |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| IMMUCELL CORP /DE/ (ICCC) | United States | $0.091B | 116.10 |
| BIOMERICA INC (BMRA) | United States | $0.011B | |
| Q/C TECHNOLOGIES, INC. (QCLS) | United States | $0.008B | -1.93 |